Lv4
476 积分 2025-01-03 加入
A graphical approach to sequentially rejective multiple test procedures
2个月前
已完结
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
3个月前
已关闭
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
3个月前
已完结
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
5个月前
已完结
TREATMENT SWITCHING IN CANCER TRIALS: ISSUES AND PROPOSALS
5个月前
已完结
Relationship Between Progression-Free Survival and Overall Survival Benefit: A Simulation Study
5个月前
已完结
A group sequential Holm precedure with multiple primary endpoints
6个月前
已完结
Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update
6个月前
已完结
American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
6个月前
已完结
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
6个月前
已完结
皖公网安备34019202002308
